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Abstract
The recently cloned NaPi-IIb cotransporter is an apical membrane protein that is involved in the absorption of phosphate in the intestine.
To expedite functional and structural studies, the human intestinal NaPi-IIb cotransporter was stably expressed in hamster fibroblast (PS120)
cells. The hNaPi-IIb cDNA stably transfected cells exhibited a 1.8-fold higher sodium-dependent phosphate uptake than vector DNA
transfected cells, and had a Km for Pi of f 106 AM and a Km for Na+ of f 34 mM. The hNaPi-IIb cotransporter was also expressed in
Xenopus oocytes and it exhibited a Km for Pi of f 113 AM and a Km for Na+ of f 65 mM. The hNaPi-IIb cotransporter expressed in both
PS120 cells and oocytes was inhibited by high external pH. Furthermore, phosphate uptake mediated by the hNaPi-IIb cotransporter was
inhibited by 5 mM phosphonoformic acid (PFA), 1 mM arsenate and 100 nM phorbol myristate acetate (PMA). These results demonstrate
that the human intestinal NaPi-IIb cotransporter is functional when expressed in hamster fibroblasts, and that this model system may be useful
in the future to identify NaPi-IIb cotransporter-specific inhibitors.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphate (Pi) plays a critical role in the body as a
constituent of bone and tooth for body development, and as
a urinary buffer for pH in body acid–base balance regu-
lation. Pi also plays a major role in cellular metabolism.
Sodium-coupled phosphate transport is the major form of Pi
absorption in the intestine, which has been studied in human
[1], rat [2–4], rabbit [5] and mouse [6]. We have previously
cloned and described a human intestinal sodium-dependent
phosphate (hNaPi-IIb) cotransporter [7]. Functional charac-
terization of this cotransporter by expression in Xenopus
oocytes and analysis of NaPi-IIb mRNA expression sug-
gested that this protein is involved in intestinal sodium-
dependent phosphate absorption [7]. Further studies showed
that the intestinal NaPi-IIb cotransporter is regulated by
hormones involved in the modulation of intestinal nutrient
absorption including epidermal growth factor (EGF) [8],
1.25 (OH)2 vitamin D3 [9] and glucocorticoids [10]. These
studies exemplified the potential importance of this trans-
porter in intestinal phosphate absorption. These previous
investigations explored the regulation of NaPi-IIb cotrans-
porter gene expression. However, extensive functional char-
acterization of the human NaPi-IIb cotransporter has not yet
been performed.
PS120 cells are fibroblast cells derived from the Chinese
hamster [11]. This cell line has been used to functionally
express and characterize several intestinal transport proteins
[12–19]. Functional expression of the human NaPi-IIb
cotransporter in a mammalian cell expression system would
allow one to perform further biological analyses, such as
membrane topology and function/structure studies, antise-
rum characterization, and studies designed to characterize
the functional cotransporter regulation.
In this communication, we demonstrate that the human
NaPi-IIb protein can be functionally expressed in PS120
cells. We further show that hNaPi-IIb cotransporter activity
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in PS120 cells exhibits similar transport kinetics as com-
pared to the oocyte expression system. Thus, the PS120 cell
expression system will allow for investigation of hNaPi-IIb
cotransporter structure/function relationships and functional
regulation, and will further allow for the identification of
specific inhibitors of the hNaPi-IIb protein.
2. Materials and methods
2.1. Plasmid construction
The entire human NaPi-IIb cDNA was isolated from the
original cloning vector, EAK8, by NotI and EcoRI digestion
[7]. The isolated insert was then ligated into the mammalian
expression vector pTarget (Promega, Madison, WI). This
vector allows for the expression of the cDNA in mammalian
cells under the control of the CMV promoter. Clones
containing the hNaPi-IIb cDNA insert were confirmed by
DNA sequencing. The final construct contained the hNaPi-
IIb cDNA, which included the full-length coding region
flanked by 35 bp of 5V-untranslated sequence and 2028 bp of
3V-untranslated sequence. Plasmid DNA used in subsequent
studies was purified with the Qiagen DNA purification kit
(Qiagen, Valencia, CA).
2.2. Cell culture
PS120 cells were a gift from Dr. Pouyssegur (University
of Nice, Nice, France). They are fibroblast-derived cells
isolated from the lung of the Chinese hamster [11]. Cells
were cultured at 37 jC in a 95% air–5% CO2 atmosphere in
DME medium supplemented with 1% penicillin–strepto-
mycin and 10% fetal bovine serum (FBS). Cells were
passaged every 48 h. Media and other reagents used for
cell culture were purchased from Irvine Scientific (Irvine,
CA).
2.3. Stable transfection
PS120 cells were cultured in 35 mm plates. When cell
density reached 60–70%, liposome-mediated transfection
was performed. Plasmid DNA (1.0 Ag) (pTarget plus hNaPi-
IIb cDNA or empty pTarget vector), and 5 Al lipofectamine
(Gibco/BRL, Grand Island, NY) were mixed with 400 Al
Opti-MEM medium (Gibco/BRL) for 30 min at room
temperature. The mixture was then added to the cells and
they were incubated for 5 h, after which an equal volume of
medium containing 20% FBS was added and the cells were
incubated overnight. The next morning, the medium was
removed and replaced with standard medium containing
10% FBS. After 48 h, the medium was replaced with G418
medium (standard medium with 10% FBS plus G418 (800
Ag/ml)). Transfected cells were cultured in G418 medium
for 7–10 days to eliminate nontransfected cells before
experiments were performed.
2.4. PCR analysis to detect NaPi-IIb expression in PS120
cells
mRNA was purified from vector or human NaPi-IIb
cDNA transfected PS120 cells using the FastTrack mRNA
Isolation Kit (Invitrogen, Carlsbad, CA). RT-PCR was
performed as previously described [8]. Primers used to
detect the NaPi-IIb transcript were designed from the human
NaPi-IIb cDNA (GenBank accession #AF146796). The
forward primer was at 1264–1283 bp (5V-TTGCATGGTT-
GACTGGCTAC-3V), and the reverse primer was at 1793–
1812 bp (5V-GCAGGAAGTTCCAGTTCTGG-3V). The
expected amplicon size was 548 bp.
2.5. Phosphate uptake measurements
Stably transfected PS120 cells were grown on 24-well
plates in the presence of G418, and phosphate uptake
was performed when cells were 95% confluent. Cells
were washed with 1.5 ml uptake buffer twice (137 mM
NaCl or choline Cl, 5.4 mM KCl, 2.8 mM CaCl2, 1.2
mM MgSO4, 10 mM Hepes/Tris, pH 7.4) and incubated
with 300 Al uptake buffer plus 0.1 mM PO4 and 1 ACi/
ml 32P-labeled PO4. After various times of incubation at
25 jC, the uptake solution was removed and cells were
washed three times with 1 ml ice-cold stop solution (137
mM NaCl, 10 mM Hepes/Tris, pH 7.4). Cells were then
lysed in 200 Al 1 passive lysis buffer (PLB) (Promega),
and aliquots were used to measure radioactivity by liquid
scintillation counting and to determine protein concen-
tration by BCA protein assay reagent kit (Pierce, Rock-
ford, IL).
For determining the apparent Km for Pi, extracellular Pi
concentration was varied between 10 AM and 1 mM, while
the pH was kept constant at 7.4. For testing the Km for Na,
extracellular Na concentration was varied between 10 and
140 mM while pH remained constant at 7.4. The Tris/Hepes
buffer system was used throughout to produce pHs between
6.0 and 8.5. After stable transfection, cells from passage five
to eight were used for the above studies. The incubation
time point was chosen in the linear portion of the time
course curve.
For inhibition studies, various inhibitors known to inhibit
other NaPi isoforms were used. The incubation time point
was chosen to be close to the saturation portion of the time
course curve. The chemical concentrations used for these
studies were: 100 nM for phorbol myristate acetate (PMA),
5 mM for phosphonoformic acid (PFA), and 1 mM for
arsenate. All these chemicals were purchased from Sigma
(St. Louis, MO).
For the calculation of sodium-dependent phosphate
absorption, phosphate uptake in the absence of sodium
was removed from uptake in the presence of sodium.
For the calculation of human NaPi-IIb protein-mediated
phosphate absorption, total sodium-dependent phosphate
uptake in vector DNA transfected PS120 cells was sub-
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tracted from total sodium-dependent phosphate uptake in
hNaPi-IIb cDNA transfected PS120 cells.
2.6. Functional characterization of the human intestinal
NaPi-IIb cotransporter in oocytes
Initially, Xenopus laevis frogs (NASCO) were anesthe-
tized in ice water with 0.05% benzocaine for 15 min.
Oocytes were then dissected from the frogs and defolli-
culated, as described previously [20]. Oocytes were main-
tained at 18 jC in Barth’s solution containing 50 mg/ml
gentamycin sulfate, 2.5 mM sodium pyruvate, and 5%
heat-inactivated horse serum. The oocytes were injected
with 50 ng of human intestinal NaPi-IIb cRNA 1 day
following isolation. Transport of KH2
32PO4 (DuPont-
NEN) was measured 3 days after injection as previously
described [21]. Oocyte uptake buffers consisted of: 100
mM NaCl (Na buffer) or 100 mM choline chloride
(choline buffer), with 2 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, and 10 mM Hepes/Tris, pH 7.5. For transport
assays, oocytes were washed briefly in choline buffer to
remove serum and then incubated in 0.4 ml of uptake
buffer. After the indicated time period, uptake was stop-
ped with four 4-ml washes of ice-cold choline buffer.
Individual oocytes were transferred to scintillation vials
and dissolved in 0.5 ml 10% SDS, and the radioactivity
was measured by scintillation counting. Counts in control
(uninjected) oocytes were subtracted from counts in
cRNA-injected oocytes. All experiments were performed
in 4–10 injected oocytes.
2.7. Curve fit and statistical analysis
All curves, including calculation of kinetic constants,
were done by nonlinear regression using the SigmaPlot
program (Jandel Scientific). ANOVA Post Hoc Tests (Stat-
View 5.0.1 version, SAS Institute, Cary, NC) were used to
compare values of the experimental data. P values of < 0.05
were considered significant.
Fig. 1. Characterization of hNaPi-IIb cotransporter expression in PS120
cells. Sodium-dependent phosphate uptake in transfected PS120 cells is
depicted. The values shown are meanF S.E. (n= 6; *P < 0.003). The inset
shows hNaPi-IIb mRNA expression in transfected PS120 cells by RT-PCR.
(pT): vector DNA transfected cells. (HNPT): hNaPi-IIb cDNA transfected
cells. (DL): 100 bp DNA ladder.
Fig. 2. Time course of sodium-dependent phosphate uptake mediated by hNaPi-IIb cotransporter in PS120 cells. Cells were incubated in uptake solution for up
to 30 min. Phosphate was added at a final concentration of 0.1 mM. The values shown are meanF S.E. (n= 5). The inset shows sodium-dependent phosphate
uptake in vector DNA (pT) or human NaPi-IIb cDNA (HNPT) transfected cells. The axis labels in the inset are the same as in the figure.
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3. Results
3.1. Characterization of human NaPi-IIb expression in
transfected PS120 cells
PS120 cells were transfected with vector DNA or vector
plus hNaPi-IIb cDNA by a liposome-mediated method.
Transfected cells were propagated in G418-containing
medium. Expression of the hNaPi-IIb cotransporter in trans-
fected PS120 cells was detected by sodium-dependent
phosphate uptake and RT-PCR. As shown in Fig. 1, a 2-
fold increase in sodium-dependent phosphate absorption
was observed from the hNaPi-IIb cDNA transfected
PS120 cells when compared with vector DNA transfected
PS120 cells. hNaPi-IIb mRNA was also detected by RT-
PCR in cDNA transfected PS120 cells (Fig. 1, inset).
3.2. Pi transport in stably transfected PS120 cells
To characterize Pi transport in transfected PS120 cells,
the relationship between Pi uptake rates and incubation
times were investigated. PS120 cells was incubated for
Fig. 3. Kinetics of phosphate transport. Panel A. Kinetics of phosphate transport mediated by human NaPi-IIb transporter in PS120 cells. Phosphate uptake was
measured within the linear portion of the uptake curve shown in Fig. 2 (12 min) at different Pi concentrations in the presence of 137 mM NaCl. The values
shown are meanF S.E. (n= 4). The inset illustrates the uptake in hNaPi-IIb cDNA (.) and vector DNA (o) transfected PS120 cells. The axis labels in the inset
are the same as in the figure. Panel B. Kinetics of phosphate transport in human NaPi-IIb cRNA injected oocytes. Five-minute Pi uptake with Pi concentrations,
between 5 and 1000 AM, was measured in the presence of 100 mM sodium. The values shown are meanF S.E. (n= 5 oocytes).
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various time periods in the presence of 100 AM Pi, and Pi
absorption was measured in the presence or absence of
sodium. Fig. 2 shows a time course study of sodium-
dependent phosphate uptake mediated by hNaPi-IIb cotrans-
porter in PS120 cells. As shown, hNaPi-IIb-mediated phos-
phate uptake increased as incubation times increased. A
linear uptake rate occurred between 10 and 20 min and
reached a plateau after 20 min. Sodium-independent uptake
was very low ( < 0.6 nmol/mg protein/30 min) in both vector
DNA and hNaPi-IIb cDNA transfected PS120 cells (data
not shown).
3.3. hNaPi-IIb cotransporter phosphate uptake kinetics
To compare Pi uptake kinetics in a mammalian cell
expression system and in an oocyte expression system, the
hNaPi-IIb cDNA or vector DNAwere transfected into PS120
cells, and hNaPi-IIb cRNA was injected into oocytes. Pi
Fig. 4. Sodium activation of phosphate cotransport. Panel A. Phosphate uptake mediated by the human NaPi-IIb cotransporter in PS120 cells. Phosphate uptake
was measured in the presence of 100 AM Pi under linear uptake conditions (12 min) as a function of sodium concentration. The values shown are meanF S.E.
(n= 4). The inset illustrates the sodium-dependent uptake in human NaPi-IIb cDNA (.) and vector DNA (o) transfected cells. The axis labels in the inset are
the same as in the figure the scale of x-axis in inset is 0, 20, 40, 60, 80, 100, 140. Panel B. Phosphate transport in human NaPi-IIb cRNA injected oocytes. Five-
minute uptake was measured in the presence of 0.1 mM phosphate plus various concentrations of Na. The values shown are meanF S.E. (n= 5 oocytes).
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uptake was measured in the presence of various phosphate
concentrations at a single time point. As shown in Fig. 3,
sodium-dependent phosphate transport mediated by hNaPi-
IIb cotransporter was concentration-dependent and saturable
in both PS120 cells and oocytes. In PS120 cells, sodium-
dependent phosphate uptake exhibited a maximal velocity
(Vmax) of 14 nmol/mg protein/12 min, with a Michaelis–
Menten constant (Km) of 106 AM (Fig. 3A). In oocytes, the
kinetics for phosphate cotransport were Vmax = 0.97 nmvl/
oocyte/5 min and Km = 113 AM (Fig. 3B).
Fig. 5. Effect of pH on phosphate transport. Panel A. Phosphate uptake mediated by the human NaPi-IIb cotransporter in PS120 cells. Fifteen-minute uptake of
0.1 mM phosphate was measured in uptake solutions adjusted to pH values ranging from 6.0 to 8.5. The values shown are meanF S.E. (n= 5; *P< 0.05). The
inset presents sodium-dependent Pi uptake in human NaPi-IIb cDNA (.) and vector DNA (o) transfected PS120 cells. The axis labels in the inset are the same
as in the figure. Panel B. Phosphate transport in human NaPi-IIb cRNA injected oocytes. Five-minute uptake of 0.1 mM phosphate was measured in uptake
solutions adjusted to pH values ranging from 5.5 to 8.5 in injected oocytes. The values shown are meanF S.E. (n= 10 oocytes per pH group; *P < 0.01).
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3.4. Sodium kinetics of the human NaPi-IIb cotransporter
The effect of Na+ ions on Pi transport mediated by the
hNaPi-IIb cotransporter was explored by measuring phos-
phate transport as a function of Na concentration. Oocytes
were injected with human NaPi-IIb cRNA, and PS120 cells
were transfected with hNaPi-IIb cDNA or vector DNA. Na-
dependent Pi uptake was measured in the presence of
various sodium concentrations and a constant Pi concen-
tration of 100 AM. There was a clear relationship between
the initial rate of phosphate transport and the sodium
concentration in hNaPi-IIb overexpressing PS120 cells, as
well as in hNaPi-IIb cRNA-injected oocytes. The hNaPi-IIb
protein generated a maximal velocity for Na+ in PS120 cells
of 4.38 nM/mg protein/12 min and the Km was 34 mM.
Similarly, in oocytes, the Vmax for Na
+ was 4.61 nM/oocyte/
5 min and the Km was 65 mM (Fig. 4B).
3.5. pH dependence of the human NaPi-IIb cotransporter
The effect of pH on human NaPi-IIb cotransporter
activity was also tested in NaPi-IIb cDNA transfected
PS120 cells and in oocytes. The pH range tested was from
6.0 (where Pi is monobasic) to 8.5 (where Pi is dibasic) [22].
The sodium-dependent Pi uptake mediated by the human
NaPi-IIb cotransporter remained relatively constant at pH
values between 6.0 and 7.5, but was significantly inhibited
at alkaline pH levels (Fig. 5A). Similar results were also
observed in hNaPi-IIb cRNA-injected oocytes (Fig. 5B).
3.6. Substrate specificity of the hNaPi-IIb cotransporter in
stably transfected PS120 cells
To further explore substrate selectivity, a variety of
compounds, including phosphate, glycine, glucose, alanine,
ascorbic acid and sulfate, were tested in hNaPi-IIb cDNA
transfected PS120 cells. The results showed that radiotracer
phosphate uptake mediated by the human NaPi-IIb protein
was not affected by 100-fold excesses (10 mM) of glycine,
glucose, alanine and ascorbic acid, but was slightly inhibited
(f 30%) by sulfate in PS120 cells (data not shown).
3.7. Inhibition study of the hNaPi-IIb cotransporter in
stably transfected PS120 cells
Arsenate, PFA and PMA have been previously shown to
inhibit sodium-dependent phosphate uptake [23–26].
Therefore, we tested the sensitivity of the human NaPi-IIb
cotransporter to these compounds. PS120 cells were trans-
fected with vector DNA or hNaPi-IIb cDNA, and sodium-
dependent Pi uptake was measured in the presence or
absence of these potential inhibitors. As shown in Fig. 6,
PFA (5 mM) inhibited nearly all of the phosphate uptake
mediated by the human NaPi-IIb transporter, while arsenate
(1 mM) only inhibited f 60% of the phosphate uptake
(Fig. 6A). PMA at a concentration of 100 nM blocked most
of the phosphate uptake mediated by the human NaPi-IIb
cotransporter (Fig. 6B).
4. Discussion
PS120 cells are fibroblast cells derived from lung tissue
of Chinese hamsters [11]. These cells have been used to
express several intestinal transport proteins, including sev-
eral sodium–hydrogen exchangers [14,16,17,19]. These
studies suggested that PS120 cells are a suitable system to
Fig. 6. Inhibition study of sodium-dependent phosphate uptake mediated by
hNaPi-IIb in PS120 cells. Uptake was measured in uptake solutions
containing various known NaPi cotransport inhibitors in PS120 cells. The
values shown are meanF S.E. (n= 6; P< 0.02). The insets present the
sodium-dependent Pi uptake in hNaPi-IIb cDNA (.) and vector DNA (o)
transfected cells. The axis labels in the insets are the same as in the figures.
Panel A shows the results in the presence of 5 mM PFA or 1 mM arsenate.
Panel B highlights the results in the presence of 100 nM PMA.
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functionally express intestinal transport proteins. Therefore,
we stably expressed the recently cloned human intestinal
sodium-dependent phosphate cotransporter (NaPi-IIb) in
PS120 cells by liposome-mediated transfection, followed
by G418 selection. The sodium-dependent phosphate uptake
in hNaPi-IIb cDNA transfected PS120 cells significantly
increased compared with uptake in vector DNA transfected
cells. This indicates that PS120 cells can functionally
express the human NaPi-IIb cotransporter, which now
makes it possible to study transport characteristics and
functional regulation of the human NaPi-IIb cotransporter
in mammalian cells. The hNaPi-IIb cotransporter expression
level in PS120 cells is modest, and this may be due to the
toxicity of high intracellular phosphate concentrations intro-
duced by overexpression of the human NaPi-IIb cotrans-
porter protein [27–29].
Functional characterization of the human NaPi-IIb co-
transporter was performed in stably transfected PS120 cells
and in the oocyte expression system. The results obtained
from these studies showed that the sodium-dependent phos-
phate transport observed in transfected PS120 cells was
similar to the activity observed in oocytes, with respect to
Km for sodium (34 mM in PS120 cells and 65 mM in
oocytes) and Km for phosphate (106 AM in PS120 cells and
112 AM in oocytes). The uptake mediated by hNaPi-IIb was
also pH-dependent, and was inhibited at alkaline pH levels.
The kinetic parameters determined in both transfected
PS120 cells and oocytes indicate that the human NaPi-IIb
cotransporter does not have a high affinity for phosphate,
and that its activity is regulated by pH. Furthermore, the
phosphate and sodium kinetics of the human NaPi-IIb
cotransporter observed in oocytes is similar to the kinetics
observed from the mouse NaPi-IIb cotransporter, although
the mouse NaPi-IIb cotransporter was not inhibited at
alkaline pH values in oocytes [30].
Substrate selectivity studies showed that sulfate slightly
inhibited phosphate uptake mediated by the human NaPi-IIb
in PS120 cells, which suggests that this cotransporter may
be involved in sulfate uptake in the intestine. However,
further studies are necessary before strong conclusions may
be drawn.
Previous studies have shown that arsenate and PFA could
inhibit phosphate absorption mediated by NaPi cotransport-
ers [21,23,26,31,32]. Our studies also showed that these
compounds significantly inhibited sodium-dependent phos-
phate absorption mediated by the human NaPi-IIb cotrans-
porter. Interestingly, PFA only inhibited a small portion
(f 29%) of endogenous sodium-dependent phosphate
uptake in vector DNA transfected PS120 cells, while it
inhibited f 55% of sodium-dependent phosphate transport
in hNaPi-IIb cDNA transfected PS120 cells (Fig. 5, insert).
This finding suggests that the human NaPi-IIb cotransporter
is more sensitive to PFA than the endogenous sodium-
dependent phosphate uptake system present in PS120 cells.
Protein kinase C (PKC) activation has been shown to
be involved in the regulation of renal Na-dependent
phosphate absorption by parathyroid hormone (PTH)
[33,34]. PMA, a potent activator of PKC, inhibited
sodium-dependent Pi uptake in mouse kidney [33] and
opossum kidney (OK) cells [35], as well as in NaPi-IIa
cRNA-injected oocytes [36,37]. PMA also inhibited
NaPi-IIb cotransporter activity in oocytes [37]. In our
PS120 cell expression system, similar results were
observed. 100 nM PMA abolished phosphate uptake
mediated by the human NaPi-IIb cotransporter, but had
no effect on the endogenous NaPi cotransporter system.
Therefore, these data suggest that the hNaPi-IIb cotrans-
porter is inhibitable by PKC activation in mammalian
cells. Further studies will be required to decipher the
molecular mechanism of this regulation.
The kinetic characterization in vector DNA transfected
PS120 cells suggested that another NaPi cotransporter(s)
is expressed in these cells (as shown in the figure
inserts). This observed activity is likely due to the
presence of type III NaPi cotransporters, which are
ubiquitously expressed in mammalian cells [21]. This
type III NaPi cotransporter was also inhibited by PFA,
arsenate and alkaline pH. However, overexpression of the
hNaPi-IIb cDNA in PS120 cells led to a significant
increase in Na-dependent Pi cotransport over background,
and this increase could be completely blocked by 5 mM
PFA and 100 nM PMA.
In summary, this study characterized the human intestinal
NaPi-IIb cotransporter in stably transfected PS120 cells and
in the oocyte expression system. Both PS120 cells and
oocytes were able to functionally express the hNaPi-IIb
cotransporter, which mediated pH-dependent NaPi cotran-
sport. PFA, PMA and arsenate inhibited the phosphate
transport mediated by the human NaPi-IIb cotransporter in
PS120 cells. We conclude that the PS120 cell expression
system might be useful to identify specific inhibitor(s) of
type IIb NaPi cotransporter.
Acknowledgements
This investigation was funded by NIH grant R01-
DK33209-17.
References
[1] S.M. Borowitz, F.K. Ghishan, Gastroenterology 96 (1989) 4–10.
[2] D.B. Lee, M.W. Walling, D.B. Corry, Am. J. Physiol. 251 (1986)
G90–G95.
[3] D.B. Lee, Adv. Exp. Med. Biol. 208 (1986) 207–212.
[4] F.K. Ghishan, N. Arab, H. Shibata, Gastroenterology 99 (1990)
106–112.
[5] S.M. Borowitz, G.S. Granrud, Am. J. Physiol. 262 (1992)
G847–G853.
[6] N. Nakagawa, F.K. Ghishan, Proc. Soc. Exp. Biol. Med. 205 (1994)
162–167.
[7] H. Xu, L. Bai, J.F. Collins, F.K. Ghishan, Genomics 62 (1999)
281–284.
H. Xu et al. / Biochimica et Biophysica Acta 1567 (2002) 97–105104
[8] H. Xu, L. Bai, J.F. Collins, K.R. Pawel, F.K. Ghishan, Am. J. Phys-
iol., Cell Physiol. 280 (2001) C628–C636.
[9] H. Xu, L. Bai, J.F. Collins, F.K. Ghishan, Am. J. Physiol., Cell
Physiol. 282 (2002) C487–C493.
[10] K. Arima, E.H. Hines, P.R. Kiela, J.B. Drees, J.F. Collins, F.K.
Ghishan, Am. J. Physiol.: Gasterointest. Liver Physiol. 283 (2002)
G426–G434.
[11] J. Pouyssegur, C. Sardet, A. Franchi, G. L’Allemain, S. Paris, Proc.
Natl. Acad. Sci. U. S. A. 81 (1984) 4833–4837.
[12] J.F. Collins, H. Xu, P.R. Kiela, J. Zeng, F.K. Ghishan, Am. J. Physiol.
273 (1997) C1937–C1946.
[13] L. Counillon, J. Pouyssegur, R.A. Reithmeier, Biochemistry 33
(1994) 10463–10469.
[14] T. Honda, S.M. Knobel, N.M. Bulus, F.K. Ghishan, Biochim. Bio-
phys. Acta 1150 (1993) 199–202.
[15] T. Ikeda, B. Schmitt, J. Pouyssegur, S. Wakabayashi, M. Shigekawa,
J. Biochem. (Tokyo) 121 (1997) 295–303.
[16] S.A. Levine, M.H. Montrose, C.M. Tse, M. Donowitz, J. Biol. Chem.
268 (1993) 25527–25535.
[17] C.M. Tse, S.A. Levine, C.H. Yun, S.R. Brant, J. Pouyssegur, M.H.
Montrose, M. Donowitz, Proc. Natl. Acad. Sci. U. S. A. 90 (1993)
9110–9114.
[18] C.M. Tse, S.A. Levine, C.H. Yun, S. Khurana, M. Donowitz, Bio-
chemistry 33 (1994) 12954–12961.
[19] J.W. Yip, W.H. Ko, G. Viberti, R.L. Huganir, M. Donowitz, C.M. Tse,
J. Biol. Chem. 272 (1997) 18473–18480.
[20] L. Bai, A.M. Pajor, Am. J. Physiol. 273 (1997) G267–G274.
[21] L. Bai, J.F. Collins, F.K. Ghishan, Am. J. Physiol., Cell Physiol. 279
(2000) C1135–C1143.
[22] D.B. Lee, M.W. Walling, U. Gafter, V. Silis, J.W. Coburn, J. Clin.
Invest. 65 (1980) 1326–1331.
[23] N. Harvey, H.S. Tenenhouse, J. Bone Miner. Res. 7 (1992) 563–571.
[24] H.S. Tenenhouse, A.H. Klugerman, J.L. Neal, Biochim. Biophys.
Acta 984 (1989) 207–213.
[25] P.C. Brazy, R.S. Balaban, S.R. Gullans, L.J. Mandel, V.W. Dennis, J.
Clin. Invest. 66 (1980) 1211–1221.
[26] B. Schroder, G. Breves, J. Comp. Physiol., B. Biochem. Syst. Envi-
ron. Physiol. 166 (1996) 230–240.
[27] C.S. Adams, K. Mansfield, R.L. Perlot, I.M. Shapiro, J. Biol. Chem.
276 (2001) 20316–20322.
[28] K. Mansfield, C.C. Teixeira, C.S. Adams, I.M. Shapiro, Bone 28
(2001) 1–8.
[29] Z. Meleti, I.M. Shapiro, C.S. Adams, Bone 27 (2000) 359–366.
[30] H. Hilfiker, O. Hattenhauer, M. Traebert, I. Forster, H. Murer, J.
Biber, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14564–14569.
[31] R.T. Timmer, R.B. Gunn, J. Gen. Physiol. 116 (2000) 363–378.
[32] R.T. Timmer, R.B. Gunn, Am. J. Physiol. 274 (1998) C757–C769.
[33] A. Boneh, S. Mandla, H.S. Tenenhouse, Biochim. Biophys. Acta
1012 (1989) 308–316.
[34] G. Quamme, J. Pfeilschifter, H. Murer, Biochim. Biophys. Acta 1013
(1989) 159–165.
[35] M.F. Pfister, J. Forgo, U. Ziegler, J. Biber, H. Murer, Am. J. Physiol.
276 (1999) F720–F725.
[36] G. Hayes, A.E. Busch, F. Lang, J. Biber, H. Murer, Pflugers Arch.
430 (1995) 819–824.
[37] I.C. Forster, M. Traebert, M. Jankowski, G. Stange, J. Biber, H.
Murer, J. Physiol. 517 (1999) 327–340.
H. Xu et al. / Biochimica et Biophysica Acta 1567 (2002) 97–105 105
